Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michal Yaakov"'
Autor:
Jorge Pfeffer, Michal Yaakov, Chen Sarbagili Shabat, Tania Musca, Franco Scaldaferri, Anastasia Godneva, Adina Weinberger, Maria Chiara Mentella, Gianluca Quaranta, Luca Masucci, Nitsan Maharshak, Caterina Fanali, Laura Turchini, Arie Levine, Nitzan Kolonimos, A Hirsch, Naomi Fliss Isakov, Eran Zittan, Yulia Ron, Nathaniel A. Cohen, Uri Kopylov
Publikováno v:
J Crohns Colitis
Background We evaluated whether integration of novel diets for donors and patients, in addition to faecal transplantation [FT], could increase FT remission rate in refractory ulcerative colitis [UC]. Methods This was a blinded, randomised, controlled
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition. 72:569-573
OBJECTIVES Pediatric ulcerative colitis (UC) is characterized by low sustained remission rates and frequent extension of disease even if clinical remission is obtained with therapy. Moderate-to-severe endoscopic activity is a risk factor for relapse
Autor:
Michal Yaakov, Dror Weiner, Eytan Wine, Arie Levine, Johan Van Limbergen, Lindsey Albenberg, Anthony R. Otley, Naomi Pressman, Chen Sarbagili-Shabat
Publikováno v:
Nutrients, 13(11):3736. Multidisciplinary Digital Publishing Institute (MDPI)
Nutrients
Volume 13
Issue 11
Nutrients, Vol 13, Iss 3736, p 3736 (2021)
Nutrients
Volume 13
Issue 11
Nutrients, Vol 13, Iss 3736, p 3736 (2021)
Background: As the microbiome plays an important role in instigating inflammation in ulcerative colitis (UC), strategies targeting the microbiome may offer an alternative therapeutic approach. The goal of the pilot trial was to evaluate the potential
Autor:
Arie Levine, Dror Weiner, Lindsey Albenberg, Eytan Wine, Anthony R. Otley, C Sarbagili Shabat, Michal Yaakov, J. van Limbergen
Publikováno v:
Journal of Crohn's and Colitis. 15:S476-S477
Background Strategies that target the microbiome may offer an alternative therapeutic approach for Ulcerative Colitis (UC). The goal of the pilot trial was to evaluate the efficacy of a novel microbe-directed UC diet (UCD) for clinical remission, as
Publikováno v:
Gastroenterology. 160:S17-S18
Background Pediatric ulcerative colitis (UC) is characterized by low sustained remission rates and frequent extension of disease even if clinical remission is obtained with therapy. Moderate to severe endoscopic activity is a risk factor for relapse
Publikováno v:
Journal of Crohn's and Colitis. 14:S530-S531
Background Pediatric ulcerative colitis (UC) is characterised by low sustained remission rates and frequent extension of disease even if clinical remission is obtained. Current therapy in pediatric UC is driven primarily by clinical response. Extensi
Autor:
C Fanali, N Fliss Isakov, C Sarbagili Shabat, J Pfeffer, Uri Kopylov, Adina Weinberger, Franco Scaldaferri, N A Cohen, Yulia Ron, Gianluca Quaranta, Maria Chiara Mentella, A Hirsch, Eran Zittan, Nitsan Maharshak, Luca Masucci, T. Musca, Laura Turchini, Arie Levine, G Anastasia, Michal Yaakov
Publikováno v:
Journal of Crohn's and Colitis. 15:S001-S001
Background We evaluated if integration of novel diets for donors and patients in addition to fecal transplantation (FT) could increase FT remission in refractory ulcerative colitis (UC) or have an independent effect on remission. We developed a novel
Autor:
Johan Van Limbergen, Dror Weiner, Chen Sarbagili-Shabat, Lindsey Albenberg, Arie Levine, Michal Yaakov
Publikováno v:
Gastroenterology. 160:S52
Background Newer strategies that target the microbiome may offer an alternative therapeutic approach for Ulcerative Colitis (UC). We developed a novel diet that targets changes in the microbiome and barrier function that have been reported in UC. The